MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Dea Registration
20 questions · exam conditions
0:00
Dea RegistrationQuestion 1 of 20

A DEA registration for a retail pharmacy must be renewed how frequently?

Every three years.
Every year.
Every five years.
Only when the pharmacy changes ownership.
← Back to quizzes

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Dea Registration

Practice Dea Registration in MPJE: Multistate Pharmacy Jurisprudence Examination with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Dea Registration, giving you a quick way to practice the rules, question types, and explanations that matter most for MPJE: Multistate Pharmacy Jurisprudence Examination.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A DEA registration for a retail pharmacy must be renewed how frequently?

  1. Every three years. (correct answer)
  2. Every year.
  3. Every five years.
  4. Only when the pharmacy changes ownership.
Explanation: DEA registrations for retail pharmacies are valid for three years and must be renewed every three years under 21 CFR 1301.13. A correctly states this renewal period. B is incorrect because annual renewal is not the standard for retail pharmacy DEA registrations; three years is the applicable period. C is incorrect because five years exceeds the three-year renewal period. D is incorrect because ownership changes may require updating the registration but they are not the only trigger; periodic renewal is required regardless.

Question 2

A pharmacy chain acquires a retail pharmacy from another company. The acquired pharmacy has an existing DEA registration. Which of the following best describes the DEA registration obligations following the acquisition?

  1. The existing DEA registration transfers automatically to the new owner upon signing the purchase agreement.
  2. The new owner must obtain a new DEA registration for the acquired location before dispensing controlled substances under the new ownership, because DEA registrations are not transferable between different legal entities. (correct answer)
  3. The new owner may continue using the previous owner's DEA registration indefinitely as long as the physical location does not change.
  4. The new owner must simply notify the DEA of the ownership change within 30 days to continue operating under the existing registration.
Explanation: DEA registrations are not transferable between legal entities. When ownership changes, the new owner must obtain its own DEA registration before dispensing controlled substances. B correctly identifies this requirement. A is incorrect because DEA registrations are not automatically transferable. C is incorrect because using another entity's registration is unauthorized and constitutes dispensing without a valid registration. D is incorrect because a simple notification does not transfer or authorize use of another entity's registration.

Question 3

A retail pharmacy's DEA registration has lapsed because the renewal was not submitted before the expiration date. Which of the following best describes the pharmacy's legal status regarding controlled substance dispensing?

  1. The pharmacy may continue to dispense for 30 days after expiration while completing the renewal application.
  2. The pharmacy must immediately cease all controlled substance dispensing activity; dispensing controlled substances after registration expiration without a valid registration is a violation of the Controlled Substances Act. (correct answer)
  3. The pharmacy may continue to dispense Schedules III through V but not Schedule II until the registration is renewed.
  4. The pharmacy may continue to dispense if the pharmacist-in-charge personally holds an individual DEA registration.
Explanation: Dispensing controlled substances without a valid DEA registration is a violation of the Controlled Substances Act. If the registration has lapsed because no timely renewal was submitted, the pharmacy must cease controlled substance dispensing immediately until the registration is renewed. B correctly identifies this. A is incorrect because the 30-day continuation provision applies only when a timely renewal was submitted before expiration. C is incorrect because all schedule dispensing requires a valid registration; there is no partial activity allowed after expiration. D is incorrect because the PIC's individual registration does not authorize the pharmacy location to dispense.

Question 4

A pharmacy's DEA registration is currently under federal investigation for potential diversion. The DEA seeks to immediately suspend the registration pending the outcome of the investigation. Under what authority may the DEA take this action?

  1. The DEA may only suspend a registration after a full adversarial hearing with the registrant present.
  2. The DEA may only suspend a registration with prior approval from the state board of pharmacy.
  3. The DEA may issue an Immediate Suspension Order if continued registration poses an imminent public health threat. (correct answer)
  4. The DEA may suspend a registration only after seeking a court order from a federal district court.
Explanation: Under 21 USC 824(d), the DEA may issue an Immediate Suspension Order without a prior hearing when continued registration poses an imminent danger to public health or safety. The registrant is entitled to an expedited hearing after the suspension. C correctly describes this authority. A is incorrect because the CSA specifically provides for immediate suspension without a prior hearing in emergency situations. B is incorrect because state board approval is not required for the DEA to exercise its independent federal suspension authority. D is incorrect because a federal court order is not required for the DEA to exercise its Immediate Suspension Order authority.

Question 5

A pharmacy opens a satellite dispensing location at a separate address across town to serve an additional patient population. Both locations will dispense controlled substances. Which of the following best describes the DEA registration requirement for the satellite location?

  1. The satellite location does not require a separate DEA registration because it is operated by the same pharmacy company and shares staff.
  2. The satellite location requires its own DEA registration because each separate location where controlled substances are dispensed must be independently registered with the DEA at that location's address. (correct answer)
  3. The satellite location is exempt from DEA registration if it dispenses fewer controlled substances than the main location.
  4. The satellite location may operate under the main pharmacy's DEA registration as long as the pharmacist-in-charge is the same individual at both sites.
Explanation: Under DEA regulations, each separate location where controlled substances are dispensed, administered, or stored must have its own DEA registration at that location's registered address. Common ownership, shared staff, or the same pharmacist-in-charge does not permit two physically separate dispensing locations to share a single DEA registration. B correctly identifies this requirement. A is incorrect because corporate or operational affiliation does not allow separate dispensing locations to operate under one registration. C is incorrect because no volume-based exemption from DEA registration exists for satellite locations. D is incorrect because the PIC's identity does not authorize two separate locations to share one DEA registration; each registered location must have its own.

Question 6

A pharmacy operating in one state wishes to expand by opening a mail-order operation that will ship controlled substance prescriptions to patients in multiple other states. Which of the following best describes the DEA registration implications?

  1. A single DEA registration at the mail-order facility is sufficient for shipping controlled substances to patients in any state.
  2. The pharmacy must obtain a separate DEA registration in each state where it will mail controlled substances.
  3. No additional DEA registration is required because the pharmacy already holds a valid DEA registration.
  4. The pharmacy needs one DEA registration but must comply with each state's laws on mailing controlled substances. (correct answer)
Explanation: A pharmacy's DEA registration covers its dispensing activities at the registered location, and a mail-order pharmacy with one DEA registration at its physical location may generally ship to patients in other states. However, state pharmacy practice acts in recipient states may impose additional licensure requirements. D correctly identifies both the DEA sufficiency and the state law compliance obligation. A is not the most complete answer because it omits the state law compliance dimension. B is incorrect because obtaining a separate DEA registration in each recipient state is not required for the dispensing pharmacy's DEA compliance. C is incorrect because while federally a single registration may be sufficient, state law compliance must also be addressed.

Question 7

A pharmacy that closed two years ago and surrendered its DEA registration at that time now wishes to reopen and resume controlled substance dispensing. Which of the following best describes the DEA registration requirement?

  1. The pharmacy may simply reactivate its previous DEA registration number by submitting a letter to the DEA.
  2. The pharmacy may resume operations under its former pharmacist-in-charge's personal DEA registration number.
  3. The pharmacy may reactivate its DEA registration by filing a reactivation form with the state board of pharmacy.
  4. The pharmacy must apply for a new DEA registration to lawfully dispense controlled substances. (correct answer)
Explanation: A surrendered DEA registration cannot be simply reactivated. The pharmacy must apply for a new registration and go through the full application process, including meeting all DEA requirements for a new registrant. D correctly identifies this requirement. A is incorrect because there is no reactivation letter process for surrendered registrations. B is incorrect because a former PIC's personal registration does not authorize a pharmacy location to operate. C is incorrect because the state board is not the mechanism for reactivating or obtaining a federal DEA registration.

Question 8

A hospital that operates both an inpatient pharmacy and a separate outpatient retail pharmacy in adjacent buildings asks whether it may use a single DEA registration for both locations. Which of the following applies?

  1. A single DEA registration may cover both locations because they are operated by the same hospital entity.
  2. A single DEA registration may cover both locations if they share the same physical address.
  3. A single DEA registration may cover both locations if the pharmacist-in-charge is the same person for both.
  4. Each pharmacy must hold a separate DEA registration; a single registration cannot cover two distinct physical locations even if operated by the same entity. (correct answer)
Explanation: DEA registrations are location-specific. Each physically distinct pharmacy location must have its own registration regardless of common ownership. D correctly identifies this requirement. A is incorrect because common ownership does not allow a single registration to cover multiple locations. B is incorrect because having adjacent addresses does not allow a single registration for physically distinct pharmacy operations. C is incorrect because sharing a PIC does not allow a single registration to cover multiple separate physical locations.

Question 9

A pharmacist employed by a hospital wants to administer a controlled substance directly to a patient as part of a clinical pharmacy service. The hospital pharmacy holds a DEA registration. Does the pharmacist need a personal DEA registration to administer?

  1. Yes, individual pharmacists must always hold a separate DEA registration before administering any controlled substance.
  2. Yes, but only if the controlled substance being administered is a Schedule II.
  3. No, the hospital's DEA registration covers pharmacists administering controlled substances within their employment scope. (correct answer)
  4. Yes, because administration requires prescribing authority which requires a separate DEA registration.
Explanation: Under the CSA, agents and employees of a DEA registrant acting in the usual course of their employment are generally covered by the registrant's DEA registration. A pharmacist administering controlled substances within the scope of hospital employment is covered by the hospital's registration. C correctly identifies this. A is incorrect because agents and employees of a registrant are generally covered by the institutional registration. B is incorrect because the schedule distinction does not determine whether a personal registration is required for employees. D is incorrect because administration is distinct from prescribing; pharmacists administering under institutional authority do not need individual prescriber registrations.

Question 10

A pharmacy's DEA registration has been revoked by the DEA following a diversion investigation. The state board of pharmacy has not yet taken action. May the pharmacy continue to dispense controlled substances under its state pharmacy license?

  1. Yes, because the state license is an independent authorization and the DEA revocation does not affect state licensing authority.
  2. No, a valid DEA registration is required to dispense controlled substances, regardless of the state pharmacy license status. (correct answer)
  3. Yes, but only for Schedules III through V because a state license is sufficient for lower-schedule substances.
  4. Yes, for 30 days while the pharmacy appeals the DEA revocation.
Explanation: A valid DEA registration is a federal prerequisite for dispensing controlled substances. State pharmacy licensure and DEA registration are both required and each is independent. DEA revocation terminates the pharmacy's federal authority to dispense controlled substances regardless of state license status. B correctly identifies this dual requirement. A is incorrect because while the state license is independent, both are required; one cannot substitute for the other. C is incorrect because all schedule dispensing requires a valid DEA registration. D is incorrect because pending appeal does not automatically stay the effect of a DEA revocation allowing continued dispensing.

Question 11

A pharmacy has applied for DEA registration renewal and the application is pending. The current registration expires while the renewal is still being processed. May the pharmacy continue to dispense controlled substances during this period?

  1. No, the pharmacy must cease all controlled substance activity immediately upon registration expiration.
  2. Yes, if the renewal application was submitted before expiration, the pharmacy may continue dispensing controlled substances. (correct answer)
  3. Yes, but only if the pharmacy notifies the state board of pharmacy about the lapse.
  4. No, the pharmacy must obtain a temporary DEA permit from its state board while the renewal is pending.
Explanation: Under 21 CFR 1301.36, if a registrant has timely submitted a renewal application before the current registration expired, the existing registration remains in effect until the DEA acts on the renewal application. B correctly describes this continuation provision. A is incorrect because a timely-filed renewal application extends the operational authority while the DEA processes the application. C is incorrect because state board notification is not required for a registration continuation during pending renewal. D is incorrect because a temporary state board permit is not required during DEA renewal processing when the application was timely submitted.

Question 12

A pharmacy has voluntarily agreed to surrender its DEA registration as part of a settlement agreement with the DEA. What happens to controlled substances remaining in the pharmacy's inventory at the time of surrender?

  1. Controlled substances must be transferred to another DEA registrant or disposed of through DEA-authorized methods. (correct answer)
  2. The pharmacist-in-charge may personally retain the controlled substances for distribution to the pharmacy's regular customers.
  3. The state board of pharmacy automatically takes custody of all remaining controlled substances upon DEA registration surrender.
  4. The pharmacy may continue dispensing remaining controlled substances until all stock is depleted, then surrender the registration.
Explanation: When a DEA registration is surrendered, remaining controlled substances must be transferred to another DEA registrant, returned to a distributor, or disposed of through a DEA-authorized method -- they cannot simply remain on the premises or be retained by the PIC. A final inventory must be conducted on the date of surrender and retained in the pharmacy's records; it is not generally required to be submitted to the DEA, but must be available for inspection. The DEA Certificate of Registration must be returned to the DEA. A correctly identifies these requirements. B is incorrect because the PIC cannot personally retain controlled substances for unofficial distribution. C is incorrect because the state board does not automatically take custody upon DEA surrender. D is incorrect because continuing to dispense controlled substances after agreeing to surrender the registration would violate the settlement terms and controlled substance laws.

Question 13

A newly licensed pharmacist sets up an independent consulting practice advising physicians on pharmacotherapy but will not personally dispense controlled substances to patients. Does this pharmacist need an individual DEA registration?

  1. No, DEA registration is not needed if the pharmacist does not handle controlled substances directly. (correct answer)
  2. Yes, all licensed pharmacists must hold individual DEA registrations as a condition of licensure.
  3. Yes, because advising physicians on pharmacotherapy implicates controlled substance management.
  4. Yes, because the DEA requires all healthcare professionals to register regardless of whether they handle controlled substances.
Explanation: DEA registration is required for practitioners who actually dispense, prescribe, or administer controlled substances. A pharmacist who provides purely advisory consulting services without personally dispensing or prescribing controlled substances does not require an individual DEA registration. A correctly identifies this. B is incorrect because pharmacist licensure does not automatically require an individual DEA registration; the activity determines the need. C is incorrect because advising physicians on pharmacotherapy does not constitute dispensing, prescribing, or administering controlled substances. D is incorrect because DEA registration is not required of all healthcare professionals; it is required of those who engage in regulated controlled substance activities.

Question 14

Under the DEA registration framework, which of the following best describes a mid-level practitioner (MLP) such as a nurse practitioner or physician assistant obtaining controlled substance prescribing authority?

  1. Mid-level practitioners may prescribe controlled substances using the supervising physician's DEA registration number.
  2. Mid-level practitioners are never authorized to prescribe controlled substances under any circumstances.
  3. Mid-level practitioners must obtain their own DEA registration to prescribe controlled substances if state law allows it. (correct answer)
  4. Mid-level practitioners may prescribe controlled substances without a DEA registration as long as they hold a valid state license.
Explanation: Mid-level practitioners authorized by their state to prescribe controlled substances must obtain individual DEA registrations in their own names. They may not use a supervising physician's DEA registration number. C correctly identifies this requirement. A is incorrect because using a supervising physician's DEA number is a federal violation. B is incorrect because many states authorize mid-level practitioners to prescribe controlled substances. D is incorrect because a state license alone does not substitute for a federal DEA registration requirement.

Question 15

A pharmacy that is moving to a new address within the same city must do which of the following regarding its DEA registration?

  1. No action is required; DEA registrations automatically transfer when a pharmacy changes its address.
  2. The pharmacy must notify the DEA after completing the move.
  3. The pharmacy must notify the DEA in advance and receive authorization before moving controlled substances to the new location. (correct answer)
  4. The pharmacy must apply for a new DEA registration at the new address, surrendering the old registration upon move completion.
Explanation: DEA regulations require pharmacies to notify the DEA before changing the registered address. A pharmacy may not move controlled substances to a new location without prior DEA notification and authorization of the address change. C correctly identifies this requirement. A is incorrect because DEA registrations do not automatically transfer; advance notification is required. B is incorrect because notification must occur in advance, not after the move. D is incorrect because an entirely new registration application is generally not required; the address change is handled through a modification process with advance notification.

Question 16

Which DEA schedule authorizes a pharmacy to dispense the broadest range of controlled substances to patients?

  1. A Schedule II-only registration.
  2. A registration limited to Schedules III through V.
  3. A state pharmacy license, which automatically grants all DEA schedule authority.
  4. A DEA registration for Schedules II-V allows dispensing of all controlled substances. (correct answer)
Explanation: A DEA registration that includes Schedule II authority encompasses Schedules II through V, allowing the pharmacy to dispense across all of these schedules. D correctly describes the scope of a full pharmacy DEA registration. A is incorrect because a Schedule II-only registration does not exist in this way; pharmacies registering for Schedule II are generally authorized for III through V as well. B is incorrect because III-V only registration would not authorize Schedule II dispensing. C is incorrect because a state pharmacy license does not automatically grant DEA authority; a separate federal DEA registration is required.

Question 17

A hospital notices that its DEA registration will expire in 60 days. When should the hospital submit its renewal application?

  1. The renewal application should be submitted at least 45 days before the expiration date to allow sufficient processing time; DEA recommends submitting 60 days before expiration. (correct answer)
  2. The renewal application may be submitted at any time after expiration, up to 30 days past the expiration date.
  3. The renewal application must be submitted on the exact expiration date.
  4. Renewal applications must be submitted at least 6 months before expiration for hospitals.
Explanation: DEA recommends submitting renewal applications at least 60 days before expiration to allow sufficient processing time, though the minimum requirement for benefit of the continuation provision is submitting before the expiration date. A correctly identifies the recommended practice. B is incorrect because submitting after expiration loses the benefit of the continuation provision that allows continued operations while renewal is pending. C is incorrect because waiting until the exact expiration date creates the risk that operations must cease if the DEA does not process the application before expiration. D is incorrect because 6 months is not required for hospital registrations.

Question 18

When a pharmacy permanently closes and surrenders its DEA registration, which of the following must occur?

  1. The pharmacy may transfer its controlled substances to any licensed pharmacist who agrees to accept them.
  2. The pharmacy's controlled substances automatically become the property of the state board of pharmacy.
  3. The pharmacy may destroy its controlled substances on site without DEA involvement.
  4. The pharmacy must return its DEA registration certificate and final inventory to the DEA. (correct answer)
Explanation: When a pharmacy closes and surrenders its DEA registration, it must complete a final inventory, arrange DEA-compliant transfer or disposal of remaining controlled substances, and return the Certificate of Registration with the final inventory. D correctly identifies these closing obligations. A is incorrect because transfer of controlled substances must follow DEA regulations, not simply be given to any pharmacist. B is incorrect because controlled substances do not automatically become state board property. C is incorrect because on-site destruction requires DEA authorization and must follow prescribed disposal requirements.

Question 19

Which of the following practitioner types must obtain a separate, individual DEA registration to prescribe controlled substances?

  1. Any licensed physician, regardless of whether they prescribe controlled substances in the usual course of their practice.
  2. Pharmacy technicians who compound controlled substance preparations under pharmacist supervision.
  3. Physicians, dentists, veterinarians, and other authorized practitioners who prescribe, administer, or dispense controlled substances in the usual course of their professional practice. (correct answer)
  4. Only practitioners who prescribe Schedule II controlled substances; practitioners prescribing only Schedules III through V do not need a DEA registration.
Explanation: Practitioners who prescribe, administer, or dispense controlled substances in the usual course of professional practice must obtain individual DEA registrations. This includes physicians, dentists, veterinarians, and other authorized mid-level practitioners. C correctly identifies this requirement. A is incorrect because a physician who does not prescribe controlled substances does not need a DEA registration. B is incorrect because pharmacy technicians performing compounding functions under a pharmacist do not require individual DEA registrations. D is incorrect because DEA registration is required for any schedule of controlled substance activity.

Question 20

A pharmacy is submitting a new DEA registration application. Under DEA regulations, who is authorized to sign the application on behalf of the pharmacy?

  1. Any licensed pharmacist currently employed at the pharmacy may sign the application.
  2. Only the pharmacy's legal owner may sign; employed pharmacists and managers are not authorized signatories regardless of their role.
  3. A proprietor, partner, or officer of the registrant organization, or the pharmacist-in-charge, is authorized to sign the DEA registration application. (correct answer)
  4. A DEA-designated compliance representative appointed by the state board of pharmacy must sign the application.
Explanation: Under 21 CFR 1301.13, a DEA registration application must be signed by a proprietor, partner, or officer of the registrant organization, or the pharmacist-in-charge. These are the expressly authorized signatories under federal regulation. C correctly identifies this framework. A is incorrect because general employment as a pharmacist does not authorize signing the registration application; the signatory must be a proprietor, partner, officer, or pharmacist-in-charge. B is incorrect because it is too narrow; partners, officers, and the pharmacist-in-charge are also authorized signatories in addition to the sole owner. D is incorrect because no DEA-designated state board compliance representative category exists for this purpose.